The following discussion and analysis of our financial condition as of December
31, 2021 and results of operations for the three and six months ended December
31, 2021 and 2020 should be read. | January 28, 2022
Geisinger Logo
WILKES-BARRE, Pa. and SUNNYVALE, Calif., May 3, 2021 /PRNewswire/
Geisinger continues to bring advanced cancer care closer to home as it is the first hospital system in the U.S. to offer Accuray Incorporated s (NASDAQ: ARAY) newest Synchrony
® technology on both the CyberKnife
® Systems to better aim radiation beams and minimize damage to non-cancerous tissue during treatment.
As part of Geisinger s expansion project at its Frank M. and Dorothea Henry Cancer Center, the health system recently began providing care using the one-of-a-kind Synchrony Motion Synchronization and Real-Time Adaptive Radiotherapy Technology on its CyberKnife S7 and Radixact Systems.
Synchrony uses artificial intelligence to adapt radiation treatment delivery in real-time to tumor movement during the treatment session, with the goal of delivering a more targeted radiation dose to the tumor, in less time, to improve outcomes. Synchrony is designed to correct the radiation beam if